HomeREGULATORY
REGULATORY

Premium Rate Threshold Could Preclude CEA-Based Price Raise for Inapplicable Products: Chuikyo Doctor Rep
(Oct.12.2017)

Dr Imamura (center) at Chuikyo Meeting on Oct. 11
A doctor member of the health ministry’s key reimbursement panel on October 11 questioned the pharma industry’s request to set a correction premium threshold for selecting products that would become subject to price adjustments under an ongoing pilot program for a Japanese version of a “cost effective assessment (CEA).” ...
(LOG IN FOR FULL STORY)

News Calendar